ММВБ 2 780 1,4%  Nasdaq 9 369 -0,5%  Биткойн 9 502 -0,7%  USD/RUB 70,6005 0,1% 
РТС 1 242 2,4%  S&P500 3 030 -0,2%  Нефть 35,0 -1,0%  EUR/RUB 78,2820 0,2% 
Dow 25 401 -0,6%  FTSE100 6 219 1,2%  Золото 1 720 0,0%  EUR/USD 1,1091 0,1% 

Курс акций Viralytics [ISIN: AU000000VLA6]

купить
продать

Viralytics LtdShs - Профиль

Viralytics is an Australian biotechnology company, listed on the Australian Stock Exchange (ASX:VLA) and is quoted on the OTC market (VRACY). Focused on developing oncolytic virotherapy for the treatment of a wide range of cancers Viralytics' headquarters are in Sydney, Australia and research and operations are in Newcastle, Australia. Oncolytic virotherapy makes use of the cancer destroying capabilities of a range of benign viruses. The potential of oncolytic virotherapy is the ability to treat cancers more effectively and with minimum side-effects.

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент